News

Features in the Media

In the news |

What to Know About Autism in Children

In an article on the early signs of autism, U.S. News & World Report features Catalight Chief Clinical Officer Doreen Samelson, Ed.D., MSCP, who suggests treatment that prioritizes a child’s needs and empowers parents to build skills into daily routines, reducing intensive therapy hours.

In the news |

The Future Of Autism: From Barriers To Breakthroughs

As autism prevalence continues to rise, builders are thinking more about designing spaces that are more welcoming to individuals with developmental disabilities. Catalight Chief Clinical Officer Doreen Samelson, Ed.D., tells Forbes that designers should consult with autistic advocates and families early to help further support inclusion.

In the news |

Integrated Autism Therapy Models Mean More Than Co-Location

In a discussion about the benefits and barriers of combining autism therapies, Catalight Chief Clinical Officer Doreen Samelson Ed.D., suggests a unified, wellbeing driven model backed by research and cost-effectiveness to boost validation and payer support.

In the news |

Using Common Sense to Weigh the Pros and Cons of Vaccination

In an op-ed about how vaccine benefits far outweigh perceived risks, Col. Eric Flake, M.D., interviews Catalight Chief Clinical Officer Doreen Samelson, Ed.D. – who shares the personal story of her son’s Rubella-related disabilities to illustrate the cost of skipping vaccines.

In the news |

Autism, Rubella and the Rising Fear of Vaccines

Catalight Chief Clinical Officer Doreen Samelson, Ed.D., shares a personal story about her son, who was exposed to rubella from his birth mother in utero. Once a common illness, rubella is now rare in the United States because of vaccines but Dr. Samelson is concerned that more parents are skipping vaccines due false belief that they cause autism.

Sign up for the Catalyst monthly newsletter
to find out what's new at Catalight.